Make sure you get your daily omega-3 intake with:


Each Fortaline® Plus capsule contains 500 mg of fish oil with 30% essential fatty acids (adopted standard: 18% EPA and 12% DHA) and 10 mg of vitamin E.

EnteriCare™ Anti-Reflux Technology (ART) softgels: clear, uncoated capsules
and uncoated, made of pectin generally recognized as safe (GRAS). EnteriCare™ technology reduces the risk of reflux and helps avoid a fishy aftertaste.

  • Children: 1 capsule per day – Adults: 1 or 2 capsules per day
  • Pregnant / nursing women: 2 to 3 capsules per day


Available in: Angola, Benin, Burkina Faso, Cameroon, Central African Republic, Ivory Coast, Democratic Republic of the Congo, Equatorial Guinea, Gabon, Guinea, Mali, Mauritania, Mozambique, Niger, Rep. of Congo, Rwanda, Senegal, Somalia, Tchad, Togo & Uganda


One teaspoon (5 ml) of Fortaline® Plus Drinkable Solution contains 4.5g fish oil (1.5g omega-3 (DHA/EPA 18/11), lemon flavour, antioxidant blend based on ascorbyl palmitate (source of vitamin C), rich extracts of toxopherol (vitamin E) and rosemary extract.

  • A daily intake of 5 ml (one teaspoon) is strongly recommended for children. Adults can take up to 10 ml.
  • It is advisable to take this product with food or with the meal to limit stomach heaviness.

Available in: Burundi, Cameroon & Rep. of Congo

Health, balance & well-being

Want more information?

Visit our website

Notice of Trademark Infringement

Dear valued partners, customers and Dafra representatives,

It has come to our attention that unauthorized use of our company’s name and logo has been observed in various contexts in the African country Togo ( In order to avoid misunderstandings, ever misleading, we feel it is imperative to address this issue promptly and transparently.

Trademark infringement poses a significant threat not only to our brand integrity but also to the trust and credibility we have worked diligently to establish within our community. Our name and logo represent our values, quality, and commitment to excellence, and any unauthorized use undermines these principles.

We take trademark infringement seriously and are actively taking measures to address any instances of unauthorized use. This includes legal action against parties found to be infringing upon our intellectual property rights.

We urge our customers, partners, African representatives and the general public to remain vigilant and report any suspected instances of trademark infringement directly to us. Your cooperation in this matter is crucial in helping us protect our brand and preserve the integrity of our business.

As always, we remain dedicated to providing high quality medical solutions in the sub-Sahara region of Africa and maintaining the highest standards of integrity and professionalism.

Thank you for your continued support and trust in our company.

Dafra Pharma